Genomic Health

Genomic Health, Inc. is a company based in Redwood City, California. It has 336 employees and generates around $500 million in annual revenue. Genomic Health specializes in providing genomic-based diagnostic tests, primarily focused on cancer care. The company's flagship product is the Oncotype IQ® Genomic Intelligence Platform, which utilizes genomic information to guide treatment decisions for cancer patients. This platform includes a portfolio of tests such as the Oncotype DX gene expression tests for breast, colon, and prostate cancer. These tests have been used to inform treatment plans for over 750,000 patients worldwide. Genomic Health is continually expanding its test offerings to include both liquid and tissue-based options, with recent additions like the Oncotype SEQ® Liquid Select™ test. Genomic Health differentiates itself by applying advanced genomic science to personalize cancer treatment. Their tests aim to optimize care by avoiding overtreatment, a significant issue in healthcare. They strive to translate the vast amounts of clinical and genomic data into actionable results for patients throughout their cancer journey, from diagnosis to monitoring. For more information about Genomic Health and its services, visit www.GenomicHealth.com.